World's Best Scientists 2026 revealed!
Stephen E. Sallan

Stephen E. Sallan

D-Index & Metrics

Medicine

D-Index
121
Citations
48026
World Ranking
3635
National Ranking
2007

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Stephen E. Sallan is affiliated with Harvard University in the United States and has contributed extensively to medical research, particularly within the field of medicine. Their work primarily focuses on topics including acute lymphoblastic leukemia research, childhood cancer survivors' quality of life, adolescent and pediatric healthcare, lymphoma diagnosis and treatment, acute myeloid leukemia research, cancer risks and factors, and folate and B vitamins research.

The scientist has published research prominently in several venues, with multiple papers appearing in "Blood," "Pediatric Blood & Cancer," "Journal of Clinical Oncology," "Blood Advances," and "Leukemia." Their publication record includes 55 works in medicine, with notable subfields being public health, environmental and occupational health, pediatrics, perinatology and child health, oncology, speech and hearing, and pathology and forensic medicine.

Stephen E. Sallan frequently collaborates with several coauthors, including Lewis B. Silverman, Yael Flamand, Lynda M. Vrooman, Andrew E. Place, and Kara M. Kelly, having coauthored numerous publications with each.

Recent significant papers by Stephen E. Sallan include:

  • Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001, 2021, Journal of Clinical Oncology
  • Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001, 2020, Pediatric Blood & Cancer
  • Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials, 2023, Blood Advances
  • Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort, 2020, Journal of Clinical Oncology
  • Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols, 2024, Leukemia

Their research topics cover:

  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Adolescent and Pediatric Healthcare
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Cancer Risks and Factors
  • Folate and B Vitamins Research

Fields of study they have contributed to include:

  • Medicine

Subfields of study encompass:

  • Public Health, Environmental and Occupational Health
  • Pediatrics, Perinatology and Child Health
  • Oncology
  • Speech and Hearing
  • Pathology and Forensic Medicine

Frequent coauthors with multiple collaborations are:

  • Lewis B. Silverman
  • Yael Flamand
  • Lynda M. Vrooman
  • Andrew E. Place
  • Kara M. Kelly

Frequent publication venues include:

  • Blood
  • Pediatric Blood & Cancer
  • Journal of Clinical Oncology
  • Blood Advances
  • Leukemia

Stephen E. Sallan is also recognized as a member of the Association of American Physicians.

Best Publications

  • Mll translocations specify a distinct gene expression profile, distinguishing a unique leukemia

    Todd R. Golub;Scott A. Armstrong;Stanley J. Korsmeyer

  • Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

    Steven E. Lipshultz;Steven D. Colan;Richard D. Gelber;Antonio R. Perez-Atayde

  • Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

    Lewis B. Silverman;Richard D. Gelber;Virginia Kimball Dalton;Barbara L. Asselin

  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

    M Smith;D Arthur;B Camitta;A J Carroll

  • Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

    Lipshultz Se;Lipsitz;Mone Sm;Goorin Am

  • Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia

    Steven E. Lipshultz;Stuart R. Lipsitz;Stephen E. Sallan;Virginia M. Dalton

  • An Oncogenic Super-Enhancer Formed Through Somatic Mutation of a Noncoding Intergenic Element

    Marc R. Mansour;Marc R. Mansour;Brian J. Abraham;Lars Anders;Alla Berezovskaya

  • Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.

    A. R. Perez-Atayde;S. E. Sallan;U. Tedrow;S. Connors

  • The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia

    Steven E. Lipshultz;Nader Rifai;Virginia M. Dalton;Donna E. Levy

  • Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

    Triona Ni Chonghaile;Kristopher A. Sarosiek;Thanh Trang Vo;Jeremy A. Ryan

  • Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association

    Steven E. Lipshultz;M. Jacob Adams;Steven D. Colan;Louis S. Constine

  • Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

    Guo Wei;Guo Wei;David Twomey;David Twomey;Justin Lamb;Krysta Schlis

  • Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

    Clavell La;Gelber Rd;Cohen Hj;Hitchcock-Bryan S

  • Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.

    Albert Moghrabi;Donna E. Levy;Barbara L. Asselin;Ronald Barr

  • Development of homozygosity for chromosome 11p markers in Wilms' tumour

    Stuart H. Orkin;Debra S. Goldman;Stephen E. Sallan

  • Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

    Steven E Lipshultz;Rebecca E Scully;Stuart R Lipsitz;Stephen E Sallan;Stephen E Sallan

  • Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification

    Scott A Armstrong;Andrew L Kung;Andrew L Kung;Meghann E Mabon;Lewis B Silverman;Lewis B Silverman

  • High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.

    Alejandro Gutierrez;Alejandro Gutierrez;Takaomi Sanda;Ruta Grebliunaite;Arkaitz Carracedo

  • Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation

    Adolfo A. Ferrando;Scott A. Armstrong;Donna S. Neuberg;Stephen E. Sallan

  • Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury

    Steven E. Lipshultz;Nader Rifai;Stephen E. Sallan;Stuart R. Lipsitz

Frequent Co-Authors

Lewis B. Silverman
Lewis B. Silverman Harvard University
Donna Neuberg
Donna Neuberg Harvard University
Steven E. Lipshultz
Steven E. Lipshultz University at Buffalo, State University of New York
Richard D. Gelber
Richard D. Gelber Harvard University
Nancy J. Tarbell
Nancy J. Tarbell Harvard University
Steven D. Colan
Steven D. Colan Boston Children's Hospital
Stuart R. Lipsitz
Stuart R. Lipsitz Brigham and Women's Hospital
Jerome Ritz
Jerome Ritz Harvard University
Harvey J. Cohen
Harvey J. Cohen Duke University
Scott A. Armstrong
Scott A. Armstrong Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but want flexible study options, there are several reputable online degrees to consider in the USA. Nursing is a rapidly growing field, and enrolling in online msn pmhnp programs allows you to specialize in psychiatric mental health while balancing work or family commitments.

For those drawn to the business side of healthcare, earning a health care administration online degree can open doors to management roles in hospitals, clinics, and insurance companies. If you’re seeking advanced leadership positions, consider a master's in healthcare administration online. These programs focus on healthcare policy, organizational behavior, and strategic decision-making.

Another pathway to leadership or advanced clinical roles is through cheap dnp online programs. With a Doctor of Nursing Practice degree, you’ll be prepared for top-level practice, research, or teaching positions in healthcare.

Each of these online options provides flexible learning, making it easier to advance your career in medicine or health-related fields while accommodating your lifestyle.

Best Scientists Citing Stephen E. Sallan

Trending Scientists

Recently Published Articles